ID   AMCPAC06
AC   CVCL_JX57
DR   cancercelllines; CVCL_JX57
DR   Cosmic; 2754414
DR   Wikidata; Q54749773
RX   PubMed=28435405;
CC   Population: Korean.
CC   Doubling time: 51 hours (PubMed=28435405).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Arg (c.34G>C); ClinVar=VCV000012579; Zygosity=Heterozygous (PubMed=28435405).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro151Ser (c.451C>T); ClinVar=VCV000012370; Zygosity=Unspecified (PubMed=28435405).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
RX   PubMed=28435405; DOI=10.1186/s12935-017-0416-8; PMCID=PMC5397831;
RA   Kim M.-J., Kim M.-S., Kim S.J., An S., Park J., Park H., Lee J.H.,
RA   Song K.-B., Hwang D.W., Chang S., Kim K.-P., Jeong S.-Y., Kim S.C.,
RA   Hong S.-M.;
RT   "Establishment and characterization of 6 novel patient-derived primary
RT   pancreatic ductal adenocarcinoma cell lines from Korean pancreatic
RT   cancer patients.";
RL   Cancer Cell Int. 17:47.1-47.15(2017).
//